newsfilter
← Latest News
GlobeNewswire·

FDA Approves Sientra's Low Plus Profile Projection Breast Implant

SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company") announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augme